MYOV - MYOVANT SCIENCES ()

MYOVのニュース

   Urovant Sciences Announces Appointment of Sef Kurstjens as Executive Vice President and Chief Medical Officer  2022/04/04 15:08:00 Kwhen Finance
   Myovant Sciences Ltd. (NYSE: MYOV) Has Succeeded In Generating Interest In 2022, The Stock Is Down -12.33% Year-To-Date  2022/03/26 13:00:00 Marketing Sentinel
Myovant Sciences Ltd. (NYSE:MYOV)’s traded shares stood at 0.4 million during the last session, with the company’s beta value hitting 2.74. At the close of trading, the stock’s price was $13.65, to imply a decrease of -5.01% or -$0.72 in intraday trading. The MYOV share’s 52-week high remains $27.43, putting it -100.95% down since that … Myovant Sciences Ltd. (NYSE: MYOV) Has Succeeded In Generating Interest In 2022, The Stock Is Down -12.33% Year-To-Date Read More »
   Myovant secures European recommendation for prostate cancer therapy  2022/02/25 15:05:50 Seeking Alpha
Commercial-stage pharma company, Myovant Sciences <> announced Friday that an expert panel of the European Medicines Agency ((EMA)) issued a positive opinion on Orgovyx for…
   Myovant Sciences Ltd. (MYOV) CEO Dave Marek on Q3 2021 Results - Earnings Call Transcript  2022/01/26 20:18:06 Seeking Alpha
   Myovant Sciences GAAP EPS of -$0.68 misses by $0.07, revenue of $54.4M in-line (NYSE:MYOV)  2022/01/26 11:56:04 Seeking Alpha
Myovant Sciences press release (NYSE:MYOV): Q3 GAAP EPS of -$0.68 misses by $0.07.Revenue of $54.4M (+3842.0% Y/Y) in-line.
   Myovant secures European recommendation for prostate cancer therapy  2022/02/25 15:05:50 Seeking Alpha
Commercial-stage pharma company, Myovant Sciences <> announced Friday that an expert panel of the European Medicines Agency ((EMA)) issued a positive opinion on Orgovyx for…
   Myovant Sciences Ltd. (MYOV) CEO Dave Marek on Q3 2021 Results - Earnings Call Transcript  2022/01/26 20:18:06 Seeking Alpha
   Myovant Sciences GAAP EPS of -$0.68 misses by $0.07, revenue of $54.4M in-line (NYSE:MYOV)  2022/01/26 11:56:04 Seeking Alpha
Myovant Sciences press release (NYSE:MYOV): Q3 GAAP EPS of -$0.68 misses by $0.07.Revenue of $54.4M (+3842.0% Y/Y) in-line.
   Myovant Sciences Q3 2021 Earnings Preview  2022/01/25 16:32:43 Seeking Alpha
Myovant Sciences (NYSE:MYOV) is scheduled to announce Q3 earnings results on Wednesday, January 26th, before market open.The consensus EPS Estimate is -$0.61 and the consensus
   Estimated ORGOVYX net product revenue of $24.2-$24.6 (NYSE:MYOV)  2022/01/10 13:20:30 Seeking Alpha
Myovant Sciences (MYOV) sees total revenues to be in the range of $54 to $55M for the quarter ended Dec.31 compared to $1.4M in year ago quarter.Net product revenue is estimated to be…
   Nancy Valente, M.D. Joins Myovant Sciences Board of Directors  2021/11/08 11:00:00 Intrado Digital Media
BASEL, Switzerland and LONDON, United Kingdom, Nov. 08, 2021 (GLOBE NEWSWIRE) -- Myovant Sciences (NYSE: MYOV), a healthcare company focused on redefining care for women and for men, today announced the appointment of Nancy Valente, M.D. as an independent member of the companys Board of Directors. Dr. Valente is a renowned expert in hematology and oncology drug development with over 20 years of experience leading global development programs at Genentech/Roche and other leading pharmaceutical companies involving novel first-in-class molecules. In addition to her Board appointment, Dr. Valente will chair the Boards Nominating and Corporate Governance Committee and be a member of the Audit Committee.
   Myovant Sciences Ltd. (NYSE:MYOV) Insider Ferreira Juan Camilo Arjona Sells 700 Shares  2021/11/07 11:22:42 Transcript Daily
Myovant Sciences Ltd. (NYSE:MYOV) insider Ferreira Juan Camilo Arjona sold 700 shares of the firms stock in a transaction that occurred on Wednesday, November 3rd. The shares were sold at an average price of $24.00, for a total value of $16,800.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which []
   Ferreira Juan Camilo Arjona Sells 700 Shares of Myovant Sciences Ltd. (NYSE:MYOV) Stock  2021/11/05 21:26:41 Dakota Financial News
Myovant Sciences Ltd. (NYSE:MYOV) insider Ferreira Juan Camilo Arjona sold 700 shares of the stock in a transaction dated Wednesday, November 3rd. The stock was sold at an average price of $24.00, for a total transaction of $16,800.00. The sale was disclosed in a filing with the SEC, which is available at the SEC website. []
   $54.59 Million in Sales Expected for Myovant Sciences Ltd. (NYSE:MYOV) This Quarter  2021/11/03 16:46:41 Dakota Financial News
Equities research analysts expect that Myovant Sciences Ltd. (NYSE:MYOV) will post $54.59 million in sales for the current quarter, Zacks Investment Research reports. Three analysts have provided estimates for Myovant Sciences earnings. The lowest sales estimate is $52.09 million and the highest is $58.40 million. Myovant Sciences reported sales of $1.38 million in the same []
   Myovant Sciences Ltd. (NYSE:MYOV) Given Average Rating of Hold by Analysts  2021/11/03 01:30:56 Dakota Financial News
Myovant Sciences Ltd. (NYSE:MYOV) has earned an average recommendation of Hold from the eight ratings firms that are currently covering the firm, MarketBeat reports. Five equities research analysts have rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average 12 month price target among brokerages that []

calendar